Serono Hold Talks With Biopharmaceutical Giants For Potential Take-over
Filed in archive Corporate and Industrial News by ruth on November 09, 2005

and Pfizer. Amgen bows out, Roger Perlmutter, vice-president of research and development saying"I don't think Amgen would be a very good partner for them (Serono)."
In addition to reproductive health, Serono has strong market positions in neurology, metabolism and growth and has recently entered the psoriasis area. Serono hired investment bank Goldman Sachs Group to explore various strategic alternatives.
Permalink: Serono Hold Talks With Biopharmaceutical Giants For Potential Take-over
Tags:
merger biotech serono potential giants serono+hold giants+potential biopharmaceutical+giants
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/10962





